Caribou Biosciences Inc (CRBU NASDAQ) stock market data APIs
$0.4491
-0.05(-11.1%)
as of November 6, 2026
Try our APIs with
free plan!
Caribou Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Prev. Close
0.4491
Open
0.4014
High
0.4517
Low
0.4001
52 wk Range
0.401-2.49
Market Cap
48 104 K
Shares Outstanding
107 M
Revenue
9 444 K
EPS
-0.25
Beta
2.488
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Caribou Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Caribou Biosciences Inc data using free add-ons & libraries
Get Caribou Biosciences Inc Fundamental Data
Caribou Biosciences Inc Fundamental data includes:
- Net Revenue: 9 444 K
- EBITDA: -102 892 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -0.27
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Caribou Biosciences Inc News
New
Caribou Bioscience GAAP EPS of -$0.25 beats by $0.02, revenue of $1.6M in-line
* Caribou Bioscience press release [https://seekingalpha.com/pr/20716424-caribou-biosciences-reports-third-quarter-2026-financial-results] (CRBU [https://seekingalpha.com/symbol/CRBU]): Q3 GAAP EPS ...
Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?
Agilent Technologies, Inc. A is slated to release fourth-quarter fiscal 2026 results on Nov. 23, after market close. The original equipment manufacturer posted adjusted earnings per share (EPS) of $1...
Caribou Biosciences, Inc. (CRBU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Caribou Biosciences, Inc. (CRBU) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known c...
Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
Travere Therapeutics (TVTX) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $0.28 per share a year ago. These fig...
Get Caribou Biosciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.